| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |